Chronic inflammatory diseases of the pelvic organs – effective treatment and recurence prevention

Authors

  • Т. Ф Татарчук Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine, Ukraine
  • Н. Ф. Захаренко Obstetrics and Gynecology of the NAM S of Ukraine, Ukraine
  • Т. І. Юско Obstetrics and Gynecology of the NAM S of Ukraine, Ukraine
  • Н. В. Яроцька Obstetrics and Gynecology of the NAM S of Ukraine, Ukraine

DOI:

https://doi.org/10.18370/2309-4117.2015.24.37-41

Keywords:

chronic inflammatory diseases of the pelvic organs, antibiotic therapy, immune biotic, grandazol®, ecobiol

Abstract

To study the effectiveness of an empirical approach to the choice of antibiotic therapy in combination with immune biotic were examined 60 women with manifest chronic recurrent inflammation of the pelvic organs. Group I included 30 women received antibiotic grandazol® for 5 days. To prevent the inflammation recurrence 30 patients (group II) with antibiotic therapy administered immune biotic ecobiol. Effectiveness of the treatment was evaluated by clinical manifestations at 3, 5, 10 days, 3 and 6 months after treatment.

As a result grandazol® was highly active against all potential agents of inflammation and had high compliance. Antibiotic and immune biotic ecobiol combination leads to the restoration of local and general immunity, provided sanitation of chronic infection in the intestine, creating the conditions for completion of the inflammatory process.

Author Biographies

Т. Ф Татарчук, Institute of Pediatrics, Obstetrics and Gynecology, NAMS of Ukraine

MD, professor, corresponding member. NAMS of Ukraine, Deputy Director for Research, Head of Endocrine Gynecology

Н. Ф. Захаренко, Obstetrics and Gynecology of the NAM S of Ukraine

MD, chief researcher at the Endocrine Gynecology Department, Institute of Pediatrics

Т. І. Юско, Obstetrics and Gynecology of the NAM S of Ukraine

Junior researcher at the Endocrine Gynecology Department, Institute of Pediatrics

Н. В. Яроцька, Obstetrics and Gynecology of the NAM S of Ukraine

Junior researcher at the Endocrine Gynecology Department, Institute of Pediatrics

References

  1. Ailamazyan, E.K., Savicheva, A.M., Bashmakova, M.A. Etiology and pathogenesis of the most important infectious diseases in obstetrics and gynecology // Mother and Child: Materials of the 2nd Russian Forum. Moscow (2000): 448–449.
  2. Buyanova, S.N., Shchukina, N.A. “Antibiotic therapy in gynecology.” Pharmatec, 2(65) 2002: 68–72.
  3. Karnatska, A.G., Vovk, I.B., Chubei, G.V. “Inflammatory diseases of the pelvic organs caused by sexually transmitted infections.” Gynecology. Review. Topic number (2012): 38–39.
  4. Krasnopolskiy, V.I., Buyanova, S.N., Shchukina, N.A. Purulent gynecology (practical guidelines). Moscow. MEDpress (2001): 282 p.
  5. Nesterov, I.M., Totolyan, A.A. Immunotherapy of infectious and inflammatory diseases of the female reproductive organs (practical guidelines). St. Petersburg (2007): 52 p.
  6. Nіkonov, A.P., Astsaturova, O.R. Infection in obstetrics and gynecology // Practical guidelines for diagnostics and antimicrobial therapy. Moscow. Borges (2003): 55 p.
  7. Prilepskaya, E.A., Zaitsev, A.V., Tupikina, N.V. “Role of the multidisciplinary campaign in the treatment of the lower urinary tract infections.” Medical Aspects of Women's Health, 1(87) (2015): 26–33.
  8. Sukhanova, A.A., Savchenko, S.E., Kolomіychenko, T.V. “Current approaches to the treatment of recurrent vulvovaginal candidiasis.” Women's Health, 7(93) (2014): 162–165.
  9. C uervo, A., Hevia, A., et al. “Association between lipid peroxidation marker, C – reactive protein, serum trace elements and fecal microbiota in lupus.” DOI :10.3305
  10. Carol, M., Borruel, N., Antolin, M., et al. “Modulation of apoptosis in intestinal lymphocytes by a probiotic bacteria in Crohn's disease.” J Leukoc Biol, 79 (2006): 917–922.
  11. D rakes, M., Blanchard, T., Czinn, S. “Bacterial probiotic modulation of dendritic cells.” Infect Immun, 72(2004): 3299–3309.
  12. Ibnou-Zekri, N., Blum, S., Schiffrin, E.J., et al. “Divergent patterns of colonization and immune response elicited from two intestinal Lactobacillus strains that display similar properties in vitro.” Infect Immun, 71(2003): 428–436.
  13. Hart, A.L., Lammers, K., Brigidi, P., et al. “Modulation of human dendritic cell phenotype and function by probiotic bacteria.” Gut, 53(2004): 1602–1609.
  14. M ogna, G., Strozzi, G.P., Mogna, L. “Bacteria strains having a high anti-inflammatory activity.” United States. Patent Application Publication, 2012, Mar. 15. US 2012/0064118 A1.
  15. N agendra P. Shah. “Functional cultures and health benefits.” J Dairy, 17 (2007): 1262–1277.
  16. Z uccotti, G.V., Meneghin, F., Raimondi, C., et al. “Probiotics in Clinical Practice: an Overview.” J Int Med Res, 36(2008) (Suppl. 1): 1А–53А.

Downloads

Published

2015-12-01

How to Cite

Татарчук, Т. Ф., Захаренко, Н. Ф., Юско, Т. І., & Яроцька, Н. В. (2015). Chronic inflammatory diseases of the pelvic organs – effective treatment and recurence prevention. REPRODUCTIVE ENDOCRINOLOGY, (24), 37–41. https://doi.org/10.18370/2309-4117.2015.24.37-41

Issue

No. 24 (2015)

Section

Gynecology

License

Copyright (c) 2015 Т. Ф Татарчук, Н. Ф. Захаренко, Т. І. Юско, Н. В. Яроцька

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.